Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189917
Status:
COMPLETED
Last Update Posted:
2019-01-10
First Post:
2005-09-11
Brief Title:
Safety Tolerability and Immune Response of IMVAMUNE MVA-BNSmallpox Vaccine in Patients With Atopic Disorders
Sponsor:
Bavarian Nordic
Organization:
Bavarian Nordic
Organization Data
Organization:
Bavarian Nordic
Class:
INDUSTRY
Study ID:
POX-MVA-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bavarian Nordic
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases NIAID | NIH |